{"id":"https://openalex.org/W4361958932","doi":"https://doi.org/10.1158/1078-0432.c.6532614","title":"Data from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma","display_name":"Data from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361958932","doi":"https://doi.org/10.1158/1078-0432.c.6532614"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6532614","doi":"https://doi.org/10.1158/1078-0432.c.6532614","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532614","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6532614","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031062394","display_name":"Vandana Batra","orcid":"https://orcid.org/0000-0003-2963-4835","observed_orcids":["https://orcid.org/0000-0003-2963-4835"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vandana Batra","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2963-4835","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081696578","display_name":"Minu Samanta","orcid":"https://orcid.org/0000-0003-2357-8748","observed_orcids":["https://orcid.org/0000-0003-2357-8748"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minu Samanta","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2357-8748","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071268972","display_name":"Mehran Makvandi","orcid":"https://orcid.org/0000-0002-6315-4942","observed_orcids":["https://orcid.org/0000-0002-6315-4942"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehran Makvandi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6315-4942","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004648124","display_name":"David Groff","orcid":"https://orcid.org/0000-0001-6897-2656","observed_orcids":["https://orcid.org/0000-0001-6897-2656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Groff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6897-2656","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002348171","display_name":"Paul Martorano","orcid":"https://orcid.org/0000-0001-8824-0065","observed_orcids":["https://orcid.org/0000-0001-8824-0065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Martorano","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8824-0065","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022832293","display_name":"Jimmy Elias","orcid":"https://orcid.org/0000-0002-1775-0356","observed_orcids":["https://orcid.org/0000-0002-1775-0356"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jimmy Elias","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1775-0356","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050323685","display_name":"Pietro Ranieri","orcid":"https://orcid.org/0000-0002-3644-8558","observed_orcids":["https://orcid.org/0000-0002-3644-8558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pietro Ranieri","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3644-8558","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048910641","display_name":"Matthew Tsang","orcid":"https://orcid.org/0000-0002-2983-2914","observed_orcids":["https://orcid.org/0000-0002-2983-2914"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Tsang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2983-2914","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082627212","display_name":"Catherine Hou","orcid":"https://orcid.org/0000-0001-8905-8492","observed_orcids":["https://orcid.org/0000-0001-8905-8492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Hou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8905-8492","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017202683","display_name":"Yimei Li","orcid":"https://orcid.org/0000-0001-9067-6992","observed_orcids":["https://orcid.org/0000-0001-9067-6992","https://orcid.org/0000-0002-7046-4316"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yimei Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9067-6992","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063084227","display_name":"Bruce Pawel","orcid":"https://orcid.org/0000-0001-7678-5324","observed_orcids":["https://orcid.org/0000-0001-7678-5324"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce Pawel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7678-5324","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042276874","display_name":"Daniel Mart\u00ednez","orcid":"https://orcid.org/0000-0002-4723-9989","observed_orcids":["https://orcid.org/0000-0002-4723-9989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Martinez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4723-9989","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003562375","display_name":"Ganesan Vaidyanathan","orcid":"https://orcid.org/0000-0003-3041-8275","observed_orcids":["https://orcid.org/0000-0003-3041-8275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ganesan Vaidyanathan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3041-8275","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050946249","display_name":"Sean Carlin","orcid":"https://orcid.org/0000-0002-5401-0648","observed_orcids":["https://orcid.org/0000-0002-5401-0648"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sean Carlin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5401-0648","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074054064","display_name":"Daniel A. Pryma","orcid":"https://orcid.org/0000-0001-8978-4419","observed_orcids":["https://orcid.org/0000-0001-8978-4419"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel A. Pryma","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8978-4419","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005797590","display_name":"John M. Maris","orcid":"https://orcid.org/0000-0002-8088-7929","observed_orcids":["https://orcid.org/0000-0002-8088-7929"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John M. Maris","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8088-7929","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.8690000176429749},{"id":"https://openalex.org/keywords/alpha-particle-therapy","display_name":"alpha therapy","score":0.6620000004768372},{"id":"https://openalex.org/keywords/astatine-211","display_name":"astatine-211","score":0.9229999780654907},{"id":"https://openalex.org/keywords/131i-mibg","display_name":"131I-MIBG","score":0.8730000257492065},{"id":"https://openalex.org/keywords/targeted-radionuclide-therapy","display_name":"targeted radionuclide therapy","score":0.7749999761581421},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7409999966621399},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9760000109672546},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.5879999995231628},{"id":"https://openalex.org/keywords/dose-fractionation","display_name":"dose fractionation","score":0.8320000171661377},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.546999990940094},{"id":"https://openalex.org/keywords/bone-marrow-relapse","display_name":"bone marrow relapse","score":0.7200000286102295},{"id":"https://openalex.org/keywords/murine-xenograft-model","display_name":"murine xenograft model","score":0.8029999732971191},{"id":"https://openalex.org/keywords/immunodeficient-mice","display_name":"immunodeficient mice","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.376716285943985},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3294197618961334},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2925376892089844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6532614","doi":"https://doi.org/10.1158/1078-0432.c.6532614","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532614","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6532614","doi":"https://doi.org/10.1158/1078-0432.c.6532614","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532614","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4286495536","https://openalex.org/W2741863434","https://openalex.org/W2282036774","https://openalex.org/W2563880051","https://openalex.org/W1602336352","https://openalex.org/W253161923","https://openalex.org/W2073017898","https://openalex.org/W4411418818","https://openalex.org/W7221002187","https://openalex.org/W3047684533"],"abstract_inverted_index":{"AbstractPurpose:":[0],"[131I]meta-iodobenzylguanidine":[1],"([131I]MIBG)":[2],"is":[3,27],"a":[4],"targeted":[5],"radiotherapeutic":[6,158],"administered":[7,147],"systemically":[8],"to":[9,107,140,151,159],"deliver":[10],"beta":[11],"particle":[12,30,239],"radiation":[13],"in":[14,18,55,74,77,90,121,130,186,212,232],"neuroblastoma.":[15,59,110,236],"However,":[16],"relapses":[17],"the":[19,49,64,83,98,157,189,213],"bone":[20],"marrow":[21],"are":[22],"common.":[23],"[211At]meta-astatobenzylguanidine":[24],"([211At]":[25],"MABG)":[26],"an":[28],"alpha":[29,238],"emitter":[31],"with":[32,79,88,148,200],"higher":[33],"biological":[34],"effectiveness":[35],"and":[36,51,70,125,170],"short":[37],"path":[38],"length":[39],"which":[40],"effectively":[41],"sterilizes":[42],"microscopic":[43,224,246],"residual":[44],"disease.":[45,225],"Here":[46],"we":[47,96],"investigated":[48],"safety":[50],"antitumor":[52,84],"activity":[53],"[211At]MABG":[54,73,87,101,115,137,211,227],"preclinical":[56],"models":[57,191,234],"of":[58,72,86,100,114,136,188,223,235],"Experimental":[60],"Design:":[61],"We":[62,81],"defined":[63],"maximum":[65],"tolerated":[66],"dose":[67,169],"(MTD),":[68],"biodistribution,":[69],"toxicity":[71,143],"immunodeficient":[75],"mice":[76,124,146,198],"comparison":[78],"[131I]MIBG.":[80,141],"compared":[82],"efficacy":[85,99],"[131I]MIBG":[89],"three":[91,190],"murine":[92],"xenograft":[93],"models.":[94],"Finally,":[95],"explored":[97],"after":[102],"tail":[103],"vein":[104],"xenografting":[105],"designed":[106],"model":[108,217],"disseminated":[109,214,233,247],"Results:":[111],"The":[112],"MTD":[113],"was":[116,138,194],"66.7":[117,164],"MBq/kg":[118,127,153,165],"(1.8":[119,166],"mCi/kg)":[120,129,155,167,176,204],"CB17SC":[122],"scid\u2212/\u2212":[123],"51.8":[126],"(1.4":[128],"NOD.Cg-Prkdcscid":[131],"Il2rgtm1Wjl/SzJ":[132],"(NSG)":[133],"mice.":[134],"Biodistribution":[135],"similar":[139],"Long-term":[142],"studies":[144],"on":[145],"doses":[149,207],"up":[150],"41.5":[152],"(1.12":[154],"showed":[156],"be":[160,243],"well":[161],"tolerated.":[162],"Both":[163],"single":[168],"fractionated":[171],"dosing":[172],"16.6":[173],"MBq/kg/fraction":[174,202],"(0.45":[175],"\u00d7":[177,205],"4":[178,206],"over":[179,208],"11":[180,209],"days":[181,210],"induced":[182],"marked":[183],"tumor":[184],"regression":[185],"two":[187],"studied.":[192],"Survival":[193],"significantly":[195],"prolonged":[196],"for":[197],"treated":[199],"12.9":[201],"(0.35":[203],"disease":[215],"(IMR-05NET/GFP/LUC)":[216],"(P":[218],"=":[219],"0.003)":[220],"suggesting":[221],"eradication":[222],"Conclusions:":[226],"has":[228],"significant":[229],"survival":[230],"advantage":[231],"An":[237],"emitting":[240],"radiopharmaceutical":[241],"may":[242],"effective":[244],"against":[245],"disease,":[248],"warranting":[249],"clinical":[250],"development.":[251]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2023-04-05T00:00:00"}